Chugai Expanding Target Range, MOAs in Antibody Drug Discovery with Its Engineering Technologies

Tomoyuki Igawa, CEO and Research Head, Chugai Pharmabody Research (right) Chugai Pharmaceutical is developing several antibody drugs by leveraging its antibody engineering technologies, which enables the company to expand the range of target molecules and explore new mechanisms of action,...read more